CoChat

Allosteric control of type I-A CRISPR-Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools

Open access
Hu, Chunyi, Ni, Dongchun, Nam, Ki Hyun, Majumdar, Sonali, McLean, Justin, Stahlberg, Henning, Terns, Michael P., Ke, Ailong · 2022 · Molecular Cell
Cited by 72

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Type I CRISPR-Cas systems typically rely on a two-step process to degrade DNA. An RNA-guided complex named Cascade first identifies the complementary DNA target. The nuclease-helicase fusion enzyme Cas3 is then recruited in trans for processive DNA degradation. Contrary to this model, here we show that Type I-A Cascade and Cas3 functions as an integral effector complex. We provide four cryo-EM snapshots of the Pyrococcus furiosus Type I-A effector complex in different stages of DNA recognition and degradation. The HD nuclease of Cas3 is autoinhibited inside the effector complex. It is only allosterically activated upon full R-loop formation, when the entire targeted region has been validated by the RNA guide. The mechanistic insights inspired us to convert Pfu Cascade-Cas3 into a high-sensitivity, low-background, and temperature-activated nucleic acid detection tool. Moreover, Pfu CRISPR-Cas3 shows robust bi-directional deletion-editing activity in human cells, which could find usage in allele-specific inactivation of disease-causing mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2022.06.007

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 72

Metadata

Authors
Hu, C., Ni, D., Nam, K. H., Majumdar, S., McLean, J., Stahlberg, H., Terns, M. P., & Ke, A.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2022-08
Volume
82
Issue
15
Pages
2754-2768.e5
ISSN
1097-2765 (ISSN-L)
OpenAlex
W4285097940
Cited by
72
References
5
FWCI
4.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.